History and Pharmacological Mechanism of Gastric Acid-suppressive Drugs

History and Pharmacological Mechanism of Gastric Acid-suppressive Drugs

Gastric acid-related disorders are commonly encountered in clinical practice. Acetylcholine, gastrin, and histamine are physiological agonists that stimulate acid secretion from parietal cells. Histamine plays a decisive role in the transformation of parietal cells into acid-secreting forms. The H+,...

Full description

Bibliographic Details
Main Authors:	Dong Han Yeom, Yong Sung Kim
Format:	Article
Language:	English
Published:	Yong Chan Lee 2023-09-01
Series:	The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Subjects:	fexuprazan histamine h2 antagonists parietal cells, gastric proton pump inhibitors tegoprazan
Online Access:	http://www.helicojournal.org/upload/pdf/kjhugr-2023-0040.pdf

Similar Items

Acid Suppressive Drugs
by: Cheol Min Shin
Published: (2022-06-01)

Assessment of the Relationship Between Gastric-Acid Suppressants and the Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis
by: Karamali Kasiri, Associate, et al.
Published: (2023-01-01)

Prediction of Ventilator-Associated Pneumonia in Patients Undergoing Stress Ulcer Prophylaxis: A Longitudinal Descriptive Study in Iran
by: Shahriar Nikpour, et al.
Published: (2020-11-01)

Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs
by: Amanda Kuhl, et al.
Published: (2020-03-01)

Indication of acid suppression therapy and predictors for the prophylactic use of proton-pump inhibitors vs. histamine-2 receptor antagonists in a Malaysian tertiary hospital
by: Oh AL, et al.
Published: (2015-09-01)

COMPARISON OF THE EFFICACIES OF PROTON PUMP INHIBITORS AND H2 RECEPTOR ANTAGONISTS IN ON-DEMAND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
by: Nesibe Vardı, et al.
Published: (2018-08-01)

Effects of Gastric Acid Secretion Inhibitors for Ventilator-Associated Pneumonia
by: Fang Li, et al.
Published: (2022-05-01)

Drug–Drug Interactions, Medication Adherence, and Stroke Should Be Considered When Approaching the Impact of Acid Suppression Therapy on Chronic Kidney Disease Patients. Comment on Chen et al. Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study. <i>J. Clin. Med.</i> 2022, <i>11</i>, 5612
by: Ai-Hsien Li, et al.
Published: (2022-12-01)

Acid-Suppressive Drugs and Risk of Fracture in Children and Young Adults: A Meta-Analysis of Observational Studies
by: Jiangbi Li, et al.
Published: (2021-08-01)

Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis
by: Biswas Sangita, et al.
Published: (2012-06-01)

The association between gastric acid inhibitors and delirium in geriatric inpatients: implications for clinical practice and research
by: Zhu LL, et al.
Published: (2016-06-01)

Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients
by: Akiomi Yoshihisa, et al.
Published: (2017-05-01)

Algorithm for pharmacists from community pharmacies who dispense over-the-counter proton pump inhibitors and histamine receptor antagonists for patients reporting symptoms of reflux
by: Elżbieta Jaworska, et al.
Published: (2024-01-01)

Impact of proton pump inhibitor management committee’s multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments
by: Lu Liu, et al.
Published: (2022-03-01)

The combined use of anti-peptic agents is associated with an increased risk of osteoporotic fracture: a nationwide case-control study
by: Dong Jun Oh, et al.
Published: (2024-03-01)

HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT
by: Schlioma ZATERKA, et al.

Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control Study
by: Chia-Jung Kuo, et al.
Published: (2021-10-01)

Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil
by: Helena Maciel-Guerra, et al.
Published: (2018-03-01)

Integration of a Physiologically Based Pharmacokinetic and Pharmacodynamic Model for Tegoprazan and Its Metabolite: Application for Predicting Food Effect and Intragastric pH Alterations
by: Hyeon-Cheol Jeong, et al.
Published: (2022-06-01)

Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study
by: Yi-Chun Chen, et al.
Published: (2022-09-01)

Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021-09-01)

Anti-Acid Drug Treatment Induces Changes in the Gut Microbiome Composition of Hemodialysis Patients
by: Yi-Ting Lin, et al.
Published: (2021-01-01)

Acid Suppression Use Among Infants in One Tertiary Children's Hospital in China, 2015–2018: A Retrospective Observational Study
by: Yue Zhou, et al.
Published: (2021-05-01)

The effect of proton-pump inhibitors on development of arrhythmia and hypomagnesaemia after off-pump coronary artery bypass surgery
by: Hasan Abbaspour, et al.
Published: (2024-12-01)

Association Between Regular Use of Gastric Acid Suppressants and Subsequent Risk of Cholelithiasis: A Prospective Cohort Study of 0.47 Million Participants
by: Man Yang, et al.
Published: (2022-01-01)

Pre-existing Proton Pump Inhibitor Treatment and Short-Term Prognosis of Acute Myocardial Infarction Patients
by: Juntao Xie, et al.
Published: (2022-07-01)

Corrigendum: Pre-existing proton pump inhibitor treatment and short-term prognosis of acute myocardial infarction patients
by: Juntao Xie, et al.
Published: (2022-07-01)

Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis
by: Xin Jiang, et al.
Published: (2019-09-01)

Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis
by: Xiaoyang Zhou, et al.
Published: (2019-11-01)

Histopathological gastric mucosal changes in patients using proton pump inhibitors
by: Saadet Alan, et al.
Published: (2020-03-01)

The Effect of H2 Receptor Antagonist in Acid Inhibition and Its Clinical Efficacy
by: Young Kwang Shim, et al.
Published: (2017-07-01)

Impact of Use of Gastric-Acid Suppressants and Oral Anti-Cancer Agents on Survival Outcomes: A Systematic Review and Meta-Analysis
by: Alice Indini, et al.
Published: (2020-04-01)

A prospective, randomized, masked, placebo‐controlled crossover study for the effect of 10 mg omeprazole capsules on gastric pH in healthy dogs
by: Ann Gaier, et al.
Published: (2021-03-01)

Which impact for proton pump inhibitors in SARS-COV-2 pneumonia
by: Grazia Mazzeo, et al.
Published: (2021-10-01)

Ten-day tegoprazan-based concomitant therapy as a first-line treatment for Helicobacter pylori eradication
by: Yong Hwan Kwon, et al.
Published: (2023-07-01)

Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine
by: Ildikó Fritz, et al.
Published: (2021-04-01)

Gastric acid suppressants and cognitive decline in people with or without cognitive impairment
by: Che‐Yuan Wu, et al.
Published: (2022-01-01)

GASTRIC FUNDIC GLAND POLYPS: CAN HISTOLOGY BE USEFUL TO PREDICT PROTON PUMP INHIBITORS USE?
by: Hugo Leite de Farias BRITO, et al.

Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis
by: Kengo Yasugi, et al.
Published: (2021-02-01)

Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: A meta-analysis
by: Zhong Li, et al.
Published: (2017-01-01)